Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11946
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMoore, Eileen Men
dc.contributor.authorAmes, Daviden
dc.contributor.authorMander, Alastair Gen
dc.contributor.authorCarne, Ross Pen
dc.contributor.authorBrodaty, Henryen
dc.contributor.authorWoodward, Michael Men
dc.contributor.authorBoundy, Karynen
dc.contributor.authorEllis, Kathryn Aen
dc.contributor.authorBush, Ashley Ien
dc.contributor.authorFaux, Noel Gen
dc.contributor.authorMartins, Ralph Nen
dc.contributor.authorMasters, Colin Len
dc.contributor.authorRowe, Christopher Cen
dc.contributor.authorSzoeke, Cassandraen
dc.contributor.authorWatters, David Aen
dc.date.accessioned2015-05-16T01:34:49Z
dc.date.available2015-05-16T01:34:49Z
dc.date.issued2014en
dc.identifier.citationJournal of Alzheimer's Disease : Jad; 39(3): 661-8en
dc.identifier.govdoc24246419en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11946en
dc.description.abstractFolate fortification of food aims to reduce the number of babies born with neural tube defects, but has been associated with cognitive impairment when vitamin B12 levels are deficient. Given the prevalence of low vitamin B12 levels among the elderly, and the global deployment of food fortification programs, investigation of the associations between cognitive impairment, vitamin B12, and folate are needed.To investigate the associations of serum vitamin B12, red cell folate, and cognitive impairment.Data were collected on 1,354 subjects in two studies investigating cognitive impairment, and from patients attending for assessment or management of memory problems in the Barwon region of south eastern Australia between 2001 and 2011. Eligible subjects who had blood measurements of vitamin B12 and red cell folate taken within six months of cognitive testing were included. Subjects with stroke or neurodegenerative diseases other than Alzheimer's disease were excluded. A Mini-Mental State Examination score of <24 was used to define impaired cognitive function.Participants with low serum vitamin B12 (<250 pmol/L) and high red cell folate (>1,594 nmol/L) levels were more likely to have impaired cognitive performance (adjusted odds ratio (AOR) 3.45, 95% confidence interval (CI): 1.60-7.43, p = 0.002) when compared to participants with biochemical measurements that were within the normal ranges. Participants with high folate levels, but normal serum vitamin B12, were also more likely to have impaired cognitive performance (AOR 1.74, 95% CI: 1.03-2.95, p = 0.04).High folate or folic acid supplements may be detrimental to cognition in older people with low vitamin B12 levels. This topic is of global significance due to the wide distribution of food fortification programs, so prospective studies should be a high priority.en
dc.language.isoenen
dc.subject.otherAlzheimer's diseaseen
dc.subject.othercognitionen
dc.subject.otherfolic aciden
dc.subject.othervitamin B12en
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherAging.blooden
dc.subject.otherAustraliaen
dc.subject.otherCognition Disorders.etiologyen
dc.subject.otherCohort Studiesen
dc.subject.otherFemaleen
dc.subject.otherFolic Acid.blooden
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMental Status Scheduleen
dc.subject.otherVitamin B 12 Deficiency.complicationsen
dc.titleAmong vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of Alzheimer's disease : JADen
dc.identifier.affiliationAustin Health, Heidelberg Repatriation Hospital, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe University of Melbourne, Florey Institute of Neuroscience & Mental Health, Parkville, Victoria, Australiaen
dc.identifier.affiliationEdith Cowan University, Centre of Excellence for Alzheimer's Disease Research & Care, School of Exercise, Biomedical and Health Sciences, Joondalup, WA, Australia Sir James McCusker Alzheimer's Disease Research Unit (Hollywood Private Hospital), Neurosciences Unit, Health Department of Western Australia, Perth, WA, Australiaen
dc.identifier.affiliationThe University of Melbourne, Florey Institute of Neuroscience & Mental Health, Parkville, Victoria, Australia The University of Melbourne, Centre for Neuroscience, Parkville, Victoria, Australiaen
dc.identifier.affiliationThe University of New South Wales, Centre for Healthy Brain Ageing and Dementia Collaborative Research Centre, Sydney, NSW, Australia Aged Care Psychiatry, Prince of Wales Hospital, Randwick, NSW, Australiaen
dc.identifier.affiliationThe Queen Elizabeth Hospital, Woodville South, SA, Australiaen
dc.identifier.affiliationBarwon Health, Geelong, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia National Ageing Research Institute, Parkville, Victoria, Australia The University of Melbourne, Florey Institute of Neuroscience & Mental Health, Parkville, Victoria, Australiaen
dc.identifier.affiliationThe University of Melbourne, Florey Institute of Neuroscience & Mental Health, Parkville, Victoria, Australia Department of Pathology, The University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia Barwon Health, Geelong, Victoria, Australiaen
dc.identifier.affiliationDepartment of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia National Ageing Research Institute, Parkville, Victoria, Australiaen
dc.identifier.affiliationAustin PET centre, Austin Hospital, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationNational Ageing Research Institute, Parkville, Victoria, Australia Preventative Health Flagship, Commonwealth Science Industry Research Organization, Parkville, Victoria, Australiaen
dc.identifier.affiliationBarwon Health, Geelong, Victoria, Australia Deakin University, School of Medicine, Waurn Ponds, Victoria, Australiaen
dc.identifier.doi10.3233/JAD-131265en
dc.description.pages661-8en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/24246419en
dc.type.austinJournal Articleen
local.name.researcherMasters, Colin L
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.languageiso639-1en-
crisitem.author.deptAged Care-
crisitem.author.deptGeriatric Medicine-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Jan 3, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.